↓ Skip to main content

Immunomodulatory drugs Revlimid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation

Overview of attention for article published in Cancer Immunology, Immunotherapy, April 2008
Altmetric Badge

Mentioned by

patent
10 patents

Citations

dimensions_citation
150 Dimensions

Readers on

mendeley
66 Mendeley
Title
Immunomodulatory drugs Revlimid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation
Published in
Cancer Immunology, Immunotherapy, April 2008
DOI 10.1007/s00262-008-0512-7
Pubmed ID
Authors

Dan Zhu, Laura G. Corral, Yuedi W. Fleming, Bernd Stein

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
United States 1 2%
France 1 2%
Unknown 63 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 26%
Student > Bachelor 9 14%
Student > Ph. D. Student 8 12%
Other 6 9%
Student > Doctoral Student 4 6%
Other 9 14%
Unknown 13 20%
Readers by discipline Count As %
Medicine and Dentistry 19 29%
Biochemistry, Genetics and Molecular Biology 9 14%
Agricultural and Biological Sciences 8 12%
Immunology and Microbiology 7 11%
Nursing and Health Professions 1 2%
Other 6 9%
Unknown 16 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2023.
All research outputs
#7,536,586
of 22,994,508 outputs
Outputs from Cancer Immunology, Immunotherapy
#1,040
of 2,895 outputs
Outputs of similar age
#28,659
of 82,363 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#15
of 26 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,895 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 82,363 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.